5/ The team is already targeting GJB2 and TMC1, two more common deafness genes, with promising animal results. We are watching gene therapy move from rare-disease fix to a platform that could one day treat most forms of genetic hearing loss.
By
–
5/ The team is already targeting GJB2 and TMC1, two more common deafness genes, with promising animal results. We are watching gene therapy move from rare-disease fix to a platform that could one day treat most forms of genetic hearing loss.